Home Search Contacts Help
ABPI - The Association of the British Pharmaceutical Industry
 
Target Rheumatoid Arthritis

Arthritis - Questions & Answers

 

What is arthritis?

Arthritis means inflammation of the joints. There are more than 200 kinds of rheumatic disease often referred to as arthritis. Some are rare, some are common. In any one year, up to 20 million people in the UK are likely to experience at least one of these diseases. It is not just a part of the ageing process.

There are several common types of arthritis:

  • Osteoarthritis usually develops gradually and affects most people over 55 to some extent.
  • Secondary arthritis sometimes develops after an injury which has damaged a joint.
  • Rheumatoid arthritis is an inflammatory disease mainly affecting joints and tendons. This booklet will focus on rheumatoid arthritis, rather than the other types.
  • Ankylosing spondylitis is also an inflammatory disease which affects the joints of the lower back and may lead to the fusion of the spine.
  • Gout arises from the formation of uric acid crystals in the joint, causing inflammation, swelling and severe pain.

top of page

 

What is rheumatoid arthritis?

Rheumatoid arthritis is a persisting inflammation of uncertain cause, mainly affecting the synovium, the membrane surrounding the moveable joints of the skeleton, but with the potential in its later stages to involve many other organs, such as the skin, lungs, nerves, blood vessels and heart. With the passage of time, the inflamed membrane increases in thickness to form pannus tissue, which invades bone, cartilage and the ligaments and leads to damage and deformity. Because it affects many body systems, rheumatologists often refer to rheumatoid disease rather than rheumatoid arthritis.

top of page

 

A healthy joint (A) and one showing some of the characteristic changes observed in rheumatoid arthritis (B) -
click for larger

How does RA start?

People usually notice symptoms of pain, swelling and stiffness in one or more joints. In about 10 per cent of people with rheumatoid arthritis, the onset is sudden and severe (this is called acute onset), in 20 per cent, the disorder develops quite quickly over a few weeks (called sub-acute onset) while in 70 per cent, symptoms develop slowly over a longer period of time (called insidious onset).

top of page

 
 

Can RA affect all joints in the body?

Although RA can affect all movable joints, it is much more common in some than others. For instance, in the hand and wrist, the joints in the middle of the fingers and the knuckles are affected in 80 to 95 per cent of people with RA, while hip, elbow and jaw joints are affected in only 20 to 50 per cent. Knee, shoulder and neck joints are somewhere in the middle.

top of page

 

How widespread is rheumatoid arthritis?

The number of adults likely to experience RA in their lifetime is about one in 100. RA affects all races and is about three times more common in women than men and especially affects women of childbearing age. Most frequently, it starts between the ages of 35 and 45, but can also affect younger people.

top of page

 

What causes rheumatoid arthritis?

No single cause for RA has been identified. Current indications are that it is an auto-immune disorder (i.e. damage caused by the body’s immune system mistakenly attacking its own tissue). It can be triggered particularly by some kinds of infection, especially in individuals who are susceptible because of their physiological and genetic make-up.

top of page

 

How is rheumatoid arthritis recognised by doctors?

Specialists in rheumatic disease have developed a set of seven criteria to decide whether someone has RA. These are assessed during clinical examination, laboratory tests and through careful questioning.

In simplified form, the most recent criteria, developed by the American Rheumatism Association, are as follows:

  • 1. Stiffness lasting at least an hour after getting out of bed before reaching the maximum improvement (‘morning stiffness’).
  • 2. Swelling of the soft tissues around at least three joints.
  • 3. Swelling of specific joints of the hand, namely the joint in the middle of the finger, and in the knuckle and wrist.
  • 4. Symmetrical arthritis (i.e. affecting the same joints on both sides of the body at the same time).
  • 5. The presence of swellings under the skin.
  • 6. A positive blood test for a substance known as rheumatoid factor.
  • 7. X-ray evidence of destruction or loss of bone in and around the joints of the hands.

A doctor will not class a condition as RA unless there are at least four of the above signs and symptoms. The first four in the list must have been present for at least 6 weeks. These criteria are 90 per cent accurate.

top of page

 


Frequency of distribution of affected joints in RA -
click for larger

What is rheumatoid factor and what is its significance?

Rheumatoid factor (RF) is the name given to certain proteins (antibodies) found in the blood of up to 85 per cent of people diagnosed with RA. The antibodies are directed against the body’s own defence system and may indicate an abnormal immune response. RF is not only found in rheumatoid arthritis but may be present in several other diseases. In fact, 5 per cent of apparently fit people have rheumatoid factors. However, the levels of rheumatoid factor are usually much higher in people with RA.

On the other hand, a person without RF may still have rheumatoid arthritis: patients with rheumatoid factor are often referred to as seropositive and those without it as seronegative. RF has very little influence on how the doctor manages the illness, but help diagnosis in its early stages. Individuals with active disease and high levels of RF have the poorest long-term prospects.

top of page

 

Is rheumatoid arthritis a serious disease?

In contrast to, say, a heart attack or stroke, where there is a sudden and dramatic medical crisis, RA often progresses gradually and is all too easy to underestimate. Most people with RA experience a reduction in their quality of life, around a half will eventually have significant disability and one third will have to give up work within a few years. Those with an aggressive form of the disease run the risk of complications affecting the heart and circulatory system. Overall, RA may shorten lifespan by 5 to 10 years but, fortunately, appropriate therapy can reduce disability by 30 per cent over 10 to 20 years.

top of page

 

Does RA follow the same pattern in all people with RA?

In an unfortunate small minority of people, RA follows a severe and aggressive course which can lead to significant disability within months. In a more fortunate minority, the initial symptoms clear up, or can be pushed into remission by early treatment. Such people can be considered to be ‘cured’. In the majority, the disease worsens slowly over a period of years, during which cartilage and bone loss gradually increases.

top of page

 

Do the genes we inherit play any part in RA?

RA has a tendency to run in families, but many cases occur without a family history. These are referred to as ‘sporadic RA’. Cases that run in the family are often associated with a gene called HLA-DR4.

However, this cannot be the whole story. HLA-DR4 occurs in about 20 to 30 per cent of the population and yet only one per cent develops RA. Most likely, genes that we inherit from our parents, like HLA-DR4, make us more susceptible to an external trigger which sets off the disease. Much evidence has accumulated over the past 50 years suggesting that the trigger is likely to be an infection by a virus, or possibly a particular type of bacterium (germ). However, attempts to identify a single organism that is responsible have so far been unsuccessful.

top of page

 


Early RA in the wrist Microfocal x-ray of a wrist, showing early erosions (EE), erosions (E), and an erosion with evidence of bony repair (EB). There is also evidence of some narrowing of joint space - click for larger

 

Is RA related to hormones?

Hormone imbalance is not a cause of RA, but several lines of evidence suggest that it can play a part in the disease, namely:

  • The higher incidence of RA in women than men (by a ratio of 3 to 1).
  • RA usually develops between the onset of puberty and the menopause.
  • RA seems to improve during pregnancy, when hormone levels are significantly modified.
  • Responses have been seen when male sex hormones are given during treatment.

top of page

 

What are the main types of medicines used in RA?

Broadly, there are four categories of medicine used to treat RA. These are called:

  • non-steroidal anti-inflammatory drugs (NSAIDs)
  • disease modifying anti-rheumatic drugs (DMARDs) which have a slow onset of action – which is why they are sometimes referred to as SAARDs (slow-acting antirheumatic drugs)
  • corticosteroids
  • biologicals, most of which are still at the clinical trial stage.

Some of these categories can be divided into subgroups according to their chemical properties and their ‘strength’. They may be supplemented by pain killers to be taken as and when needed.

top of page

 

Are these medicines used for different purposes?

Generally, yes. The NSAIDs are designed to control inflammation and pain, but do not alter the progression of the disease. The DMARDs are often taken together with NSAIDs to contain the disease, reduce the swelling and minimise incapacity. However, this must be done under medical supervision, as there can be potential side effects if they are taken together. Steroids may be injected into a troublesome joint during a flare-up, or in acute-onset disease. Clinical trials using low dose steroids taken by mouth suggest that they may be able to reduce joint erosion, but further studies are needed.

Biologicals are the most recent and exciting development, most of them arising from the new science of genetic engineering. Nearly all are still at the experimental or clinical trial stage, but they are of considerable theoretical interest and, if successful, may greatly reduce the long-term damage brought about by RA.

top of page

 

When are these medicines likely to be used?

The most common practice is to use a ‘cascade’ approach, beginning with a medicine to help ease the pain (an analgesic) and possibly an NSAID to control both pain and inflammation. The choice of NSAID is very wide and will depend to some extent on the severity of the symptoms and on the patient’s history. If control is not achieved, it may be necessary to switch to a different NSAID. Increasingly, DMARDs (which include methotrexate, gold salts, chloroquine, penicillamine, and sulfasalazine) are being used within the first six months, because recent experience suggests that this may give better results.

In many hospital clinics today, more than 50 per cent of people with RA are treated almost from the outset with combinations of NSAIDs and DMARDs. However, long-term follow-up studies over many years suggest that even with this strategy, combinations may have only a small effect on bone erosion, though they can greatly improve the quality of life by reducing the pain and swelling. Even so, it is very important that people diagnosed as having RA are quickly referred by their GP to a specialist, so that early combination treatment can be considered.

top of page

 

Is it true that some people do not respond to treatment with medicine?

Individual response to the medicines used to treat RA is very variable. What suits one person may not suit another. In such cases, a doctor will select an alternative NSAID from the many available or switch the person on to a different DMARD. However, once a response has been obtained, it can be long lasting. In such cases, it is tempting to discontinue therapy, but recent research has suggested that people with RA who are doing well on their medication should still continue to take it, as this reduces the chance of a relapse. Unfortunately, a very small minority do not respond to a lot of the medicines available.

top of page

 

Do medicines for RA have a lot of side effects?

NSAIDs may have a number of side effects, but how they develop is dependent on the individual. Thus one person may find the side effects unacceptable, while the same medicine may be entirely satisfactory in the next. The most troublesome and widely experienced side effects are upsets to the digestive system – including weight loss, nausea and pain in the pit of the stomach. In some cases, NSAIDs damage the stomach, leading to the formation of ulcers and, rarely, to severe internal bleeding. Different products vary greatly in their tendency to cause these effects and a number of approaches to lessen this problem have been explored. All the DMARDs also have side-effects; these differ widely from medicine to medicine, so their use has to be monitored carefully.

top of page

 


Distribution of damage in the wrist and hands in RA – a: very early, b: early, c: moderately advanced - click for larger


Prescribing anti-inflammatory and anti-rheumatic medicines. Adding a DMARD is now widely practised - click for larger

What kind of general support is available for people with RA?

As well as seeing a GP and a specialist in rheumatology for treatment, there are many other forms of support available. One is the physiotherapist, who aims to ensure that joints are kept as flexible and mobile as possible. This may involve sessions of:

  • Electrotherapy (ultra-sound, infra-red, or pulses of short wave energy) to help reduce inflammation and injury.
  • Prescribed exercises.
  • Hydrotherapy in a warm pool.
  • Other relaxation, mobility and manipulative techniques.

The physiotherapist will also be able to advise on the choice of aids for walking and on other specialised aspects such as the use of Transcutaneous Electronic Nerve Stimulation (TENS) for easing pain. Patients may also need to see an occupational therapist, who can advise on special instruments to make everyday tasks easier, such as dressing, cooking, bathing, turning on a tap, undoing a jar, gardening, etc. (see Box on page 9). People who feel they need this help and are having difficulty getting a referral can turn to organisations such as Arthritis Care, who will be able to provide guidance. They can also contact their local social services department and request an assessment under the NHS and Community Care Act of 1990.

Many people also decide to try an alternative therapy such as osteopathy or chiropractic. Before doing this, it is advisable to discuss it with a doctor and to seek information such as Arthritis Care’s The Balanced Approach. Such organisations will also be able to give specific advice on aspects such as diet, exercise and rest and how to look after joints. Arthritis Care also runs courses in arthritis self-management with the aim of increasing self-confidence and putting people more in control of their lives.

 

Examples of some of the many activities for which specialist equipment is available to help in your everyday life

  • Turning taps
  • Opening tins, bottles and jars
  • Cutting vegetables
  • Writing
  • Slicing bread
  • Washing
  • Grating cheese
  • Bathing
  • Peeling potatoes
  • Dressing
  • Pouring drinks
  • Squeezing toothpaste
  • Picking things up from the floor
  • Combing hair
  • Cleaning
  • Cutting/filing nails
  • Turning keys
  • Putting on shoes, socks, tights

 

top of page

 
 

Are joint replacements always necessary?

Replacing joints by surgery may become necessary when their function is almost lost or the pain becomes too intense. Joint replacement, especially for osteoarthritis, has transformed the quality of life for thousands of people and is now a common procedure. Many joints can be replaced, including the fingers, knees and elbows, but the best known and probably the most successful is hip replacement.

The materials used, such as stainless steel, are chosen so that they are not rejected by the body and have an acceptably long use before needing to be replaced. Despite the success of these operations, they are often preceded by years of pain and suffering; the objective of the search for new medicines to treat RA must be to develop therapies that prevent this stage ever being reached.

top of page

 

 

 

< Previous Page | Contents | Next Page >
 
 
Previous Page | Print Page | Top of Page
Copyright © ABPI - The Association of the British Pharmaceutical Industry Terms and Conditions | Privacy Policy